Recruiting Stroke Studies in New Haven
Strategy for Improving Stroke Treatment Response
SISTER is a Phase-II, prospective, randomized, placebo-controlled, blinded, dose finding trial that aims to determine the safety and preliminary efficacy of TS23, a monoclonal antibody against the alp...
Regulating Blood Pressure During Recovery From Intracerebral Hemorrhage and Ischemic Stroke
The purpose of this research study is to determine whether blood pressure treatment regimens with spironolactone are better than blood pressure treatment regimens without spironolactone at lowering bl...
About Stroke Clinical Trials in New Haven
A stroke occurs when blood flow to part of the brain is interrupted or reduced, depriving brain tissue of oxygen and nutrients. It is a leading cause of disability and death. Rapid treatment is critical, and prevention focuses on managing risk factors like hypertension and atrial fibrillation.
There are currently 2 stroke clinical trials recruiting participants in New Haven, CONNECTICUT. These studies are seeking a combined 500 participants. Research is being sponsored by Translational Sciences, Inc., Yale University. Clinical trial participation is free and participants receive study-related medical care at no cost.
Stroke Clinical Trials in New Haven — FAQ
Are there stroke clinical trials in New Haven?
Yes, there are 2 stroke clinical trials currently recruiting in New Haven, CONNECTICUT. Browse the studies on this page to find one that fits.
How do I join a clinical trial in New Haven?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the New Haven research site will contact you about next steps.
Are clinical trials in New Haven free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many New Haven studies also compensate for your time and travel.
What stroke treatments are being tested?
The 2 active trials in New Haven are testing new therapies including novel drugs, biologics, and treatment approaches for stroke.
Data updated March 2, 2026 from ClinicalTrials.gov